Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KGHM Polska Miedź S.A. is a major Polish multinational corporation and one of the world's leading producers of copper and silver. While primarily an industrial mining giant, the company maintains a significant presence in the healthcare sector through its subsidiary, Miedziowe Centrum Zdrowia (MCZ), which operates a network of hospitals and diagnostic centers in Poland. KGHM also engages in life science research through its R&D arm, KGHM Cuprum, focusing on the antimicrobial properties of copper (Cu+) for medical applications and environmental health. The company is a critical component of the Polish healthcare infrastructure, providing specialized medical services and occupational health programs. KGHM is publicly traded on the Warsaw Stock Exchange and is headquartered in Lubin, Poland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KGHM.